K-Line Chart, actual market data is subject to the trading page.
Key Data
Prev. Open
$0.60
Prev. Close
$0.74
Prev. Day's Range
$0.60 - $0.75
52W Range
$0.53 - $2.55
Trading Volume
20.522M
MC
$204.154M
P/E Ratio
--
EPS
$-0.66
Company Overview
NASDAQ
Humacyte Inc (HUMA) is a pioneering biotechnology company specializing in vascular and regenerative medicine, with a focus on the development of human acellular vessels (HAVs). These innovative off-the-shelf products address critical needs in vascular reconstruction and chronic disease management, enhancing patient outcomes while potentially lowering healthcare costs. Utilizing its advanced technology platform, Humacyte is strategically positioned to lead advancements in transplantation and tissue engineering, solidifying its role as a transformative force in the evolving medical therapies landscape.
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Headquarters2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, UNITED STATES, 27713
Settled in USDT, supports up to 20x leverage, allows for two-way trading (long/short), no need to hold underlying assets, suitable for short-term trend trading and hedging.
Investment Nature:Hold underlying tokenized assets, 1:1 pegged to US stocks, with prices fluctuating in sync with the original Nasdaq shares.
Dividend Rights:Based on company policy. When the underlying stock pays dividends, the platform distributes equivalent dividends in USDT according to holding proportions.
Suitable For:Long-term investors, value investors, and users who are optimistic about the company's long-term growth and wish to hold assets to enjoy dividends.
Risk:Stock price volatility risk: investment principal may face losses, and long-term holding involves bearing cyclical market fluctuations.
Trading Rules:Settled in USDT, trade 24/7 with no minimum deposit requirement. One account supports both spot and futures trading.
HUMA operates in the healthcare sector, specializing in innovative solutions for medical research and patient care technologies. The company’s core business includes developing advanced tools to improve health outcomes and streamline clinical studies. HUMA focuses on leveraging technology to address gaps in healthcare delivery, making it a key player in its industry.
HUMA is part of the healthcare technology industry, which combines medical advancements with digital tools. Its competitors typically include companies specializing in similar segments, such as digital health platforms and AI-based clinical research solutions. Rival companies may vary depending on specific areas of focus within the industry.
HUMA generates revenue through its healthcare technologies and services that enhance medical research and patient outcomes. Key drivers include ongoing adoption of technological solutions across healthcare providers, partnerships with clinical institutions, and scaling its efforts in research-led healthcare initiatives.
HUMA currently does not pay dividends, as many healthcare technology companies reinvest earnings into research, development, and expansion. Investors should consider whether the company’s growth-focused strategy aligns with their portfolio goals before investing.
HUMA presents opportunities for investors due to its focus on healthcare technology, which is a growing and evolving sector. The company’s innovative approaches to medical research and improving patient care could offer long-term growth potential. However, risks include market competition and the need for consistent funding to support expansion.
Investors should weigh risks such as potential competition from other healthcare technology companies, regulatory challenges in the industry, and dependence on market adoption of its innovations. Additionally, scalability and continued investment in development remain critical factors for the company’s success.
HUMA’s valuation within the healthcare technology industry depends on factors like revenue growth, profitability, and market positioning. Investors can compare its key metrics, such as price-to-earnings or price-to-sales ratios, with industry peers to determine its relative value and potential.
HUMA positions itself for growth by focusing on technological innovation, strategic partnerships, and addressing unmet needs in healthcare delivery. The company’s commitment to advancing patient outcomes and enhancing medical research processes serves as a foundation for long-term growth opportunities.
Risk Warning
1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
3.The information contained on this page is for reference only and does not constitute any investment advice.
